The emerging role of the hedgehog signaling pathway in gastrointestinal cancers.
Thayer
Sarah
S
Division of General Surgery, Massachusetts General Hospital, USA.
D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D019521:Body Patterning / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D005770:Gastrointestinal Neoplasms / Q000503:physiopathology*; D015870:Gene Expression; D018507:Gene Expression Regulation, Developmental; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000235:genetics; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D015398:Signal Transduction / Q000502:physiology*; D014157:Transcription Factors / Q000502:physiology; D014947:Wounds and Injuries / Q000235:genetics; D000071676:Zinc Finger Protein GLI1
D000970:Antineoplastic Agents; C400551:GLI1 protein, human; D053823:Hedgehog Proteins; D009363:Neoplasm Proteins; D014157:Transcription Factors; D000071676:Zinc Finger Protein GLI1